Villere ST Denis J & Co. LLC Buys 209,502 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Villere ST Denis J & Co. LLC lifted its stake in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 18.5% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,344,608 shares of the company’s stock after purchasing an additional 209,502 shares during the quarter. Option Care Health comprises 2.8% of Villere ST Denis J & Co. LLC’s investment portfolio, making the stock its 11th biggest holding. Villere ST Denis J & Co. LLC owned about 0.79% of Option Care Health worth $31,195,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds also recently made changes to their positions in the company. UMB Bank n.a. lifted its position in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company’s stock valued at $27,000 after acquiring an additional 346 shares in the last quarter. GAMMA Investing LLC lifted its position in Option Care Health by 110.6% in the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock valued at $28,000 after acquiring an additional 471 shares in the last quarter. Whittier Trust Co. of Nevada Inc. lifted its position in Option Care Health by 3,362.8% in the 3rd quarter. Whittier Trust Co. of Nevada Inc. now owns 1,489 shares of the company’s stock valued at $47,000 after acquiring an additional 1,446 shares in the last quarter. International Assets Investment Management LLC lifted its position in Option Care Health by 3,029.7% in the 3rd quarter. International Assets Investment Management LLC now owns 2,848 shares of the company’s stock valued at $91,000 after acquiring an additional 2,757 shares in the last quarter. Finally, Quarry LP lifted its position in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company’s stock valued at $107,000 after acquiring an additional 2,628 shares in the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Trading Down 1.1 %

Shares of OPCH stock opened at $31.46 on Friday. The company has a 50 day moving average of $26.69 and a 200-day moving average of $27.93. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. Option Care Health, Inc. has a 12-month low of $21.39 and a 12-month high of $34.63. The firm has a market cap of $5.35 billion, a P/E ratio of 26.44, a PEG ratio of 2.19 and a beta of 1.35.

Analyst Ratings Changes

Several equities analysts recently weighed in on OPCH shares. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research report on Monday, January 13th. The Goldman Sachs Group cut shares of Option Care Health from a “buy” rating to a “neutral” rating and dropped their price target for the company from $38.00 to $27.00 in a research report on Monday, November 4th. JPMorgan Chase & Co. lifted their target price on shares of Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Barrington Research lifted their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research report on Tuesday, January 14th. Finally, Jefferies Financial Group raised shares of Option Care Health from a “hold” rating to a “buy” rating and lifted their target price for the stock from $26.00 to $35.00 in a research report on Thursday, January 23rd. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Option Care Health presently has an average rating of “Moderate Buy” and a consensus price target of $32.25.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.